EMEA-001066-PIP02-11-M03
Key facts
Invented name |
Sitavig and associated names
|
Active substance |
Aciclovir
|
Therapeutic area |
Infectious diseases
|
Decision number |
P/0412/2019
|
PIP number |
EMEA-001066-PIP02-11-M03
|
Pharmaceutical form(s) |
Muco-adhesive buccal tablet
|
Condition(s) / indication(s) |
Treatment of herpes simplex labialis
|
Route(s) of administration |
Gingival use
|
Contact for public enquiries |
Vectans Pharma
Tel. +33 631268926 |
Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|